4th Quarter - Amendment

NVG, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 19, 2021 $60,000 Replaced
4th Quarter - Amendment (this page) Jan 21, 2021 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —
EDEN SHIFERAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4049 (116th), H.R. 6395 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.